Showing results (301-310 of 391) with videos related to
Sort By:
Pageof 40
The Journal of Clinical Endocrinology and Metabolism|September 1, 1989
Sex steroids and bone density in premenopausal and perimenopausal womenK K Steinberg, L W Freni-Titulaer, E G DePuey, et al.Journal of the American Academy of Child and Adolescent Psychiatry|December 22, 1999
The MacArthur Three-City Outcome Study: evaluating multi-informant measures of young children's symptomatologyJ C Ablow, J R Measelle, H C Kraemer, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 29, 2012
Seroprevalence of tularemia in rural AzerbaijanDanielle V Clark, Afrail Ismailov, Esmiralda Seyidova, et al.Journal of Cachexia, Sarcopenia and Muscle|June 26, 2013
Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3-creatine dilution methodStephen A Stimpson, Michael S Leonard, Lisa G Clifton, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2022
CRISPR base editing of cis-regulatory elements enables the perturbation of neurodegeneration-linked genesColin K W Lim, Tristan X McCallister, Christian Saporito-Magriña, et al.BMC Infectious Diseases|October 30, 2019
Direct-from-blood RNA sequencing identifies the cause of post-bronchoscopy feverEmily R Ko, Casandra W Philipson, Thomas W Burke, et al.Journal of Minimally Invasive Gynecology|September 24, 2017
Review of Sterilization Techniques and Clinical UpdatesNisse V Clark, Scott P Endicott, Elisa M Jorgensen, et al.Emerging Infectious Diseases|June 25, 2024
Evidence of Orientia spp. Endemicity among Severe Infectious Disease Cohorts, UgandaPaul W Blair, Kenneth Kobba, Stephen Okello, et al.Applied and Environmental Microbiology|June 2, 2022
On the Environmental Presence of Burkholderia pseudomallei in South-Central GhanaGeorge Oduro, F J Lourens Robberts, Paul K A Dartey, et al.International Journal of Clinical Pharmacology and Therapeutics|November 2, 2004
Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young menA R van Troostenburg, E V Clark, W D H Carey, et al.Pageof 40